Literature DB >> 35132153

Impact and interactions between risk factors on the iron status of at-risk neonates.

Christine E Brichta1,2, Jennie Godwin3, Sally Norlin2, Pamela J Kling4,5.   

Abstract

OBJECTIVE: Examine interactions between perinatal risk factors for congenital iron deficiency (ID) using two cohorts. STUDY
DESIGN: Iron status in a composite 767-member cord blood cohort and a NICU cohort of 257 infants < 33 weeks of gestation or small for gestational age (SGA). Risks for ID were examined. Cord ferritin levels < 84 µg/L defined congenital ID. Serum ferritin < 70 µg/L defined infantile ID at one-month.
RESULTS: 31% of the cord cohort had congenital ID; risks summative (p < 0.0015). 16% of the NICU cohort had infantile ID; risks not summative. However, 32% had ID if the ferritin threshold was 100 µg/L. Being both preterm (p < 0.0001) and SGA (p < 0.05) negatively impacted cord iron status. Maternal hypertension was a novel predictor of iron status (p = 0.023 in preterm cord; p < 0.0025 in NICU).
CONCLUSION: Summing risks in term and understanding compounding risks in preterm infants can improve screening and management of ID in at-risk infants.
© 2022. The Author(s), under exclusive licence to Springer Nature America, Inc.

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 35132153     DOI: 10.1038/s41372-022-01318-4

Source DB:  PubMed          Journal:  J Perinatol        ISSN: 0743-8346            Impact factor:   3.225


  43 in total

1.  Diagnosis and prevention of iron deficiency and iron-deficiency anemia in infants and young children (0-3 years of age).

Authors:  Robert D Baker; Frank R Greer
Journal:  Pediatrics       Date:  2010-10-05       Impact factor: 7.124

2.  Iron deficiency and anemia are prevalent in women with multiple gestations.

Authors:  Yuan Ru; Eva K Pressman; Elizabeth M Cooper; Ronnie Guillet; Philip J Katzman; Tera R Kent; Stephen J Bacak; Kimberly O O'Brien
Journal:  Am J Clin Nutr       Date:  2016-08-31       Impact factor: 7.045

3.  Elevated zinc protoporphyrin/heme ratios in umbilical cord blood after diabetic pregnancy.

Authors:  K B Lesser; S B Schoel; P J Kling
Journal:  J Perinatol       Date:  2006-10-05       Impact factor: 2.521

4.  Iron deficiency in early childhood in the United States: risk factors and racial/ethnic disparities.

Authors:  Jane M Brotanek; Jacqueline Gosz; Michael Weitzman; Glenn Flores
Journal:  Pediatrics       Date:  2007-09       Impact factor: 7.124

5.  Erythrocyte zinc protoporphyrin is elevated with prematurity and fetal hypoxemia.

Authors:  David G Lott; M Bridget Zimmerman; Robert F Labbé; Pamela J Kling; John A Widness
Journal:  Pediatrics       Date:  2005-08       Impact factor: 7.124

Review 6.  The assessment of newborn iron stores at birth: a review of the literature and standards for ferritin concentrations.

Authors:  Ashajyothi M Siddappa; Raghavendra Rao; Jeffrey D Long; John A Widness; Michael K Georgieff
Journal:  Neonatology       Date:  2007-03-14       Impact factor: 4.035

7.  Predictors of serum ferritin and serum soluble transferrin receptor in newborns and their associations with iron status during the first 2 y of life.

Authors:  Gry Hay; Helga Refsum; Andrew Whitelaw; Elisabeth Lind Melbye; Egil Haug; Berit Borch-Iohnsen
Journal:  Am J Clin Nutr       Date:  2007-07       Impact factor: 7.045

8.  Iron stocks and risk of anemia in twins.

Authors:  S Ben Miled; D Bibi; N Khalfi; R Blibech; Y Gharbi; R Castalli; N Khrouf
Journal:  Arch Inst Pasteur Tunis       Date:  1989 Jul-Oct

9.  Neonatal iron status is impaired by maternal obesity and excessive weight gain during pregnancy.

Authors:  A K Phillips; S C Roy; R Lundberg; T W Guilbert; A P Auger; S E Blohowiak; C L Coe; P J Kling
Journal:  J Perinatol       Date:  2014-03-20       Impact factor: 2.521

10.  Maternal obesity during pregnancy is negatively associated with maternal and neonatal iron status.

Authors:  A D Jones; G Zhao; Y-P Jiang; M Zhou; G Xu; N Kaciroti; Z Zhang; B Lozoff
Journal:  Eur J Clin Nutr       Date:  2016-01-27       Impact factor: 4.016

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.